Ethically Accepted With Code 851/2971 A Comparison of Class Ⅱ Malocclusion Treatment Using Van Beek-headgear Activator Versus Andresen Activator
NCT ID: NCT05604625
Last Updated: 2022-11-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
24 participants
INTERVENTIONAL
2022-12-15
2023-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Micro-osteoperforation on Rate of Maxillary En-masse Retraction
NCT03764189
Evaluation Of Anchorage Control During Canine Retraction Using Arch Wire Stopper Versus Mini-Screws
NCT06416904
Twin Block Appliance in Incremental Versus Maximum Bite Advancement in Skeletal Class II
NCT04562545
Class II Malocclusion Correction Using the Mini-screw Supported Advanced Molar Distalization Appliance
NCT06726694
Evaluation of Skeletal and Dental Effect of the New Hybrid Aesthetic Functional Appliance
NCT06209125
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
12 patients will receive Van-Beek activator and a headgear
Van-Beek activator and a headgear
12 patients will receive Van-Beek activator and a headgear
Group B
12 patients will receive Andresen activator
Andresen activator
12 patients will receive Andresen activator.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Van-Beek activator and a headgear
12 patients will receive Van-Beek activator and a headgear
Andresen activator
12 patients will receive Andresen activator.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Class II division 1 with overjet \> 5mm.
* An age range between 8 and 13 years growing patient using cervical vertebral stage assessment (CVS).
* No previous orthodontic treatment
* No indications or symptoms of periodontal disease in the past or present, as determined by clinical and radiographic examination
Exclusion Criteria
* Craniofacial anomalies.
* Medical condition or prescription medication that may affect growth.
* Lack of compliance whenever documented in the charts.
8 Years
13 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al-Azhar University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Essam Eldein Saad Hamed Shady
doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alazhar University
Cairo, Cairo Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Altenburger E, Ingervall B. The initial effects of the treatment of Class II, division 1 malocclusions with the van Beek activator compared with the effects of the Herren activator and an activator-headgear combination. Eur J Orthod. 1998 Aug;20(4):389-97. doi: 10.1093/ejo/20.4.389.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
851/2971
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.